| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/22/2013 | WO2013120618A1 Recombinant escherichia coli strains |
| 08/22/2013 | WO2013120529A1 New calicivirus |
| 08/22/2013 | WO2013120143A1 Method of promoting the formation of cross-links between coiled coil silk proteins |
| 08/22/2013 | WO2013093045A3 Cyclotides as immunosuppressive agents |
| 08/22/2013 | WO2013076580A3 Recombinant proteins and their therapeutic uses |
| 08/22/2013 | WO2013068430A3 High mast2-affinity polypeptides and uses thereof |
| 08/22/2013 | WO2013064830A3 Medical use |
| 08/22/2013 | US20130219571 Polypeptide having swollenin activity and uses thereof |
| 08/22/2013 | US20130219567 Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same |
| 08/22/2013 | US20130219561 Stress tolerant plants and methods thereof |
| 08/22/2013 | US20130219532 Peptides with antifungal activities |
| 08/22/2013 | US20130217865 Tumor Specific Antibody |
| 08/22/2013 | US20130217864 Human interleukin-1 receptor antagonist - hybrid fc fusion protein |
| 08/22/2013 | US20130217859 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217758 Multiantivirus compound, composition and method for treatment of virus diseases |
| 08/22/2013 | US20130217637 Mutant ngal proteins and uses thereof |
| 08/22/2013 | US20130217636 Compositions and methods for treatment of gynecologic cancers |
| 08/22/2013 | US20130217633 Inhibitors of bcl-2 |
| 08/22/2013 | US20130217628 Therapeutically Active Alpha-MSH Analogues |
| 08/22/2013 | US20130217626 Novel Bioactive Protein Isolated From Chinese Yam and Uses Thereof |
| 08/22/2013 | US20130217625 Compositions and methods for producing bioactive fusion proteins |
| 08/22/2013 | US20130217623 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 08/22/2013 | US20130217616 Chimeric inhibitor molecules of complement activation |
| 08/22/2013 | US20130217612 Complete genome sequence of the methanogen methanobrevibacter ruminantium |
| 08/22/2013 | US20130217129 Conditioned cell culture medium compositions and methods of use |
| 08/22/2013 | US20130217122 Expansion of Interferon-Gamma-Producing T-Cells Using Glypican-3 Peptide Library |
| 08/22/2013 | US20130217116 Peptide II |
| 08/22/2013 | US20130217097 Cell with improved secretion mediated by mrga protein or homologue |
| 08/22/2013 | US20130217076 Polypeptide capable of enhancing cellulosic biomass degradation |
| 08/22/2013 | US20130217069 Conditioned cell culture medium compositions and methods of use |
| 08/22/2013 | US20130217067 Combinatorial DNA Library for Producing Modified N-Glycans In Lower Eukaryotes |
| 08/22/2013 | US20130217048 Immunizing Compositions and Methods of Use |
| 08/22/2013 | US20130216613 Cytomegalovirus gb antigen |
| 08/22/2013 | US20130216604 Polypeptide for inhibiting metastasis, uses thereof, and pharmaceutical compositions containing the same |
| 08/22/2013 | US20130216588 Insulin-gold nanocluster, pharmaceutical composition for reducing blood glucose comprising the same, and method for detecting adipose cells in tissue by using the same |
| 08/22/2013 | US20130216579 Methods and compostitions for gene editing of a pathogen |
| 08/22/2013 | US20130216570 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 08/22/2013 | US20130216568 Immunogenic proteins and compositions |
| 08/22/2013 | US20130216567 Avian group d rotavirus |
| 08/22/2013 | US20130216566 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 08/22/2013 | US20130216563 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof |
| 08/22/2013 | US20130216541 Stable subcutaneous protein formulations and uses thereof |
| 08/22/2013 | US20130216539 Methods of Generation and Treatment with Modified Derivatives of HSP 70 |
| 08/22/2013 | US20130216500 Method of treating or retarding the development of blindness |
| 08/22/2013 | US20130216496 Methods for treating tweak-related conditions |
| 08/22/2013 | US20130216479 Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adducts |
| 08/21/2013 | EP2628793A1 Recombinant escherichia coli strains |
| 08/21/2013 | EP2628750A2 Targeted identification of immunogenic peptides |
| 08/21/2013 | EP2628749A2 Antimicrobial kinocidin compostions and methods of use |
| 08/21/2013 | EP2628748A1 Angiostatin chimeras and uses thereof |
| 08/21/2013 | EP2628747A1 Impaired wound healing compositions and treatments |
| 08/21/2013 | EP2628009A2 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |
| 08/21/2013 | EP2627767A1 Polypeptides with permease activity |
| 08/21/2013 | EP2627674A2 Egfr-based peptides |
| 08/21/2013 | EP2627671A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
| 08/21/2013 | EP2627670A2 Novel n-terminally modified insulin derivatives |
| 08/21/2013 | EP2627669A1 Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| 08/21/2013 | EP2627668A1 Peptides and uses |
| 08/21/2013 | EP2627667A1 Production of plants having improved water-deficit tolerance |
| 08/21/2013 | EP2627666A2 Nitrilases with improved activity |
| 08/21/2013 | EP2627665A1 Methods and compositions for treating hemophilia b |
| 08/21/2013 | EP2627634A1 A new dimedon derivative and a method for the purification of pna and peptide oligomers |
| 08/21/2013 | EP2627352A2 Novel antigen |
| 08/21/2013 | EP2627351A2 Antigen delivery platforms |
| 08/21/2013 | EP2627348A1 Method for purification of complement factor h |
| 08/21/2013 | EP2627347A1 Uses of macrophage mannose receptor to screen compounds and uses of these compounds |
| 08/21/2013 | EP2627201A1 Antimicrobial protein |
| 08/21/2013 | EP2627168A1 Als inhibitor herbicide tolerant beta vulgaris mutants |
| 08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2013 | CN1909922B Novel flavivirus antigens |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261409A Mannanase, coding gene and production thereof |
| 08/21/2013 | CN103261231A Chimeric spider silk and uses thereof |
| 08/21/2013 | CN103261219A Mutant channelrhodopsin 2 |
| 08/21/2013 | CN103261218A Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy |
| 08/21/2013 | CN103261217A Soluble pd-1 variants, fusion constructs, and uses thereof |
| 08/21/2013 | CN103261216A Modified protein body tags and production methods thereof |
| 08/21/2013 | CN103261215A Drought tolerant plants and related constructs and methods involving genes encoding mate-efflux polypeptides |
| 08/21/2013 | CN103261214A Vaccines with live bacterial isolates for systemic administration |
| 08/21/2013 | CN103261213A Lactococcus crispr-as sequences |
| 08/21/2013 | CN103260743A Polymeric complements to [beta]-amyloid peptides |
| 08/21/2013 | CN103260644A Parapoxvirus vectors containing rabies virus antigen |
| 08/21/2013 | CN103260641A Treatment and prevention of malaria |
| 08/21/2013 | CN103255167A Method for producing tethered proteins |
| 08/21/2013 | CN103255162A Erythropoietin compositions |
| 08/21/2013 | CN103255151A Coded sequence CVN (Cyanovirin-N) mutant with high expression quantity and high activity and application of coded sequence |
| 08/21/2013 | CN103255150A Magnaporthe grisea MoLON1 gene function and application thereof |
| 08/21/2013 | CN103255146A Arabidopsis thaliana nitrate transporter gene NRT2.1, encoding protein and applications thereof |
| 08/21/2013 | CN103255145A Arabidopsis thaliana heat shock transcription factor gene HSFA3, encoding protein and applications thereof |
| 08/21/2013 | CN103255108A Cell adhesion molecule 5 monoclonal antibody, preparation method and applications thereof |
| 08/21/2013 | CN103255096A Gene engineering bacterium capable of performing high-efficiency expression on Alpha-elaterin-protein and construction method and application thereof |
| 08/21/2013 | CN103254316A Antimicrobial peptide with drug-resistance bacteria resistance activity and synthesis and application thereof |
| 08/21/2013 | CN103254306A Purification process for glycosylated hemoglobin |
| 08/21/2013 | CN103254305A Preparation method of acetic acid redfish calcitonin |
| 08/21/2013 | CN103254304A Immune stimulant couplet, preparation method thereof and antineoplastic application of the immune stimulant couplet |
| 08/21/2013 | CN103254303A Preparation method and application of antineoplastic active polypeptide component in Arca subcrenata Lischke |
| 08/21/2013 | CN103254302A Method for separation of antitumor polypeptide compound from Arca subcrenata Lischke and application |
| 08/21/2013 | CN103254301A Plant disease resistance related protein GbMBL1, its coding gene and application |
| 08/21/2013 | CN103254300A Plant antioxidation-related protein SsPETE1, and coding gene and application thereof |